Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ewing's sarcoma

R S Iyer1, S R Rao, A Gurjal

  • 1Department of Medical Oncology, Tata Memorial Hospital, Bombay, India.

Journal of Surgical Oncology
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.

Indian journal of cancer·2016
Same author

Comparison of isolates and antibiotic sensitivity pattern in pediatric and adult cancer patients; is it different?

Indian journal of cancer·2016
Same author

Spinal metastasis of breast cancer presenting after 25 years: An extremely rare presentation.

The Gulf journal of oncology·2015
Same author

Application of PET-MRI in pseudo progression versus true progression in High Grade Gliomas: A new avenue!

Journal of neurosciences in rural practice·2014
Same author

The diagnostic value of CT myelography, MR myelography, and both in neonatal brachial plexus palsy.

AJNR. American journal of neuroradiology·2014
Same author

A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.

Indian journal of cancer·2012
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
Same journal

A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

Journal of surgical oncology·2026
Same journal

How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

Journal of surgical oncology·2026
Same journal

New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

Journal of surgical oncology·2026
See all related articles

This study on Ewing's sarcoma found that a combined VDC chemotherapy and radiotherapy protocol resulted in a 5-year survival rate of 36%. More aggressive treatment is needed for high-risk cases.

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Cancer Research

Background:

  • Ewing's sarcoma is a rare bone cancer primarily affecting children and young adults.
  • Combined modality treatment protocols are standard for managing Ewing's sarcoma.
  • Optimizing treatment strategies is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of a combined modality protocol for Ewing's sarcoma of the bone.
  • To identify prognostic factors influencing survival in patients with Ewing's sarcoma.

Main Methods:

  • A cohort of 50 patients with bone Ewing's sarcoma received induction VDC chemotherapy followed by radiotherapy.
  • Patients underwent six additional cycles of VDC chemotherapy post-radiotherapy.
  • Statistical analysis using Lee-Desu methods was employed to determine survival factors.

Related Experiment Videos

Main Results:

  • The 5-year disease-free survival was 38.0% and overall survival was 36.0%.
  • Twenty-five patients experienced relapse, with local failure occurring in five and local and distant metastasis in four.
  • Response to therapy was identified as the sole significant factor for survival.

Conclusions:

  • The current combined VDC chemotherapy and radiotherapy protocol shows limited long-term survival rates for Ewing's sarcoma.
  • More aggressive therapeutic approaches, including optimized local treatment (surgery and/or radiotherapy), are necessary for high-risk patients.
  • Further research is needed to enhance survival outcomes in Ewing's sarcoma management.